Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Published Online: 2015-10-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Andrea Tannapfel•Anke Reinacher-Schick•Axel Hinke•Birgitta Killing•Christian A Lerchenmüller•Claus-Christoph Steffens•Dirk Arnold•Georg Dietrich•Hans-Joachim Schmoll•Jan Stoehlmacher•Julia Quidde•Reinhard Depenbusch•Salah-Eddin Al-Batran•Susanna Hegewisch-Becker•Tanja Trarbach•Thoralf Lange•Ullrich Graeven
